# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-044124
Filing Date
2024-11-08
Accepted
2024-11-07 21:09:28
Documents
40
Period of Report
2024-11-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 38880
2 |  | ex99-1.htm | EX-99.1 | 28442
3 |  | ex99-1_001.jpg | GRAPHIC | 166640
4 |  | ex99-1_002.jpg | GRAPHIC | 678350
5 |  | ex99-1_003.jpg | GRAPHIC | 343711
6 |  | ex99-1_004.jpg | GRAPHIC | 274292
7 |  | ex99-1_005.jpg | GRAPHIC | 298540
8 |  | ex99-1_006.jpg | GRAPHIC | 342922
9 |  | ex99-1_007.jpg | GRAPHIC | 306711
10 |  | ex99-1_008.jpg | GRAPHIC | 308663
11 |  | ex99-1_009.jpg | GRAPHIC | 261127
12 |  | ex99-1_010.jpg | GRAPHIC | 288096
13 |  | ex99-1_011.jpg | GRAPHIC | 309830
14 |  | ex99-1_012.jpg | GRAPHIC | 275270
15 |  | ex99-1_013.jpg | GRAPHIC | 321884
16 |  | ex99-1_014.jpg | GRAPHIC | 295926
17 |  | ex99-1_015.jpg | GRAPHIC | 292302
18 |  | ex99-1_016.jpg | GRAPHIC | 367542
19 |  | ex99-1_017.jpg | GRAPHIC | 267916
20 |  | ex99-1_018.jpg | GRAPHIC | 290088
21 |  | ex99-1_019.jpg | GRAPHIC | 329960
22 |  | ex99-1_020.jpg | GRAPHIC | 342264
23 |  | ex99-1_021.jpg | GRAPHIC | 276616
24 |  | ex99-1_022.jpg | GRAPHIC | 287081
25 |  | ex99-1_023.jpg | GRAPHIC | 415734
26 |  | ex99-1_024.jpg | GRAPHIC | 372125
27 |  | ex99-1_025.jpg | GRAPHIC | 325365
28 |  | ex99-1_026.jpg | GRAPHIC | 136819
| Complete submission text file | 0001493152-24-044124.txt |  | 11508339

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
29 | XBRL SCHEMA FILE | ltrn-20241107.xsd | EX-101.SCH | 3030
30 | XBRL LABEL FILE | ltrn-20241107_lab.xml | EX-101.LAB | 34240
31 | XBRL PRESENTATION FILE | ltrn-20241107_pre.xml | EX-101.PRE | 24175
42 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3793

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 241437734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)